Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine to improve physicochemical properties for potential veterinary use. Issue 35 (9th August 2019)
- Record Type:
- Journal Article
- Title:
- Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine to improve physicochemical properties for potential veterinary use. Issue 35 (9th August 2019)
- Main Title:
- Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine to improve physicochemical properties for potential veterinary use
- Authors:
- Wang, Xinyi
Xu, Shijie
Jia, Lina
Yang, Yujia
Liu, Yu
Gong, Junbo
Wu, Songgu - Abstract:
- Abstract : Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine were designed to improve the solubility and hygroscopicity, which could possibly extend the drug–drug salt form into veterinary use. Abstract : The incorporation of drug–drug salts is known as an attractive strategy to not only improve physicochemical properties but also extend the field of combination drug delivery. Mefenamic acid (MFA) and tolfenamic acid (TFA) belong to effective but poorly soluble anti-inflammatory drugs used for treating both humans and animals. Piperazine (PPZ) has anthelmintic activities with a serious hygroscopic problem. To improve the physicochemical properties of such drugs and seek possible drug combinations, herein, four novel MFA\TFA–piperazine (PPZ) drug–drug salts with different stoichiometry (2 : 1 and 1 : 1) were designed and synthesized. As we expected, the experiments proved that their solubilities and dissolution properties were much better than that of MFA and TFA. Among them, the apparent solubility of the MFA–PPZ salt (1 : 1) improved about 130 times more than that of MFA in a mixture of water and ethanol. Meanwhile, these salts were non-hygroscopic based on dynamic vapor sorption analysis. Moreover, the obtained crystals were fully analyzed by single-crystal X-ray diffraction (SXRD), Hirshfeld surface analysis and a solvent mediated phase transformation study, which provided a better understanding of the crystal structure. The MFA–PPZ salt (2 : 1) and TFA–PPZAbstract : Drug–drug salts of mefenamic acid\tolfenamic acid and piperazine were designed to improve the solubility and hygroscopicity, which could possibly extend the drug–drug salt form into veterinary use. Abstract : The incorporation of drug–drug salts is known as an attractive strategy to not only improve physicochemical properties but also extend the field of combination drug delivery. Mefenamic acid (MFA) and tolfenamic acid (TFA) belong to effective but poorly soluble anti-inflammatory drugs used for treating both humans and animals. Piperazine (PPZ) has anthelmintic activities with a serious hygroscopic problem. To improve the physicochemical properties of such drugs and seek possible drug combinations, herein, four novel MFA\TFA–piperazine (PPZ) drug–drug salts with different stoichiometry (2 : 1 and 1 : 1) were designed and synthesized. As we expected, the experiments proved that their solubilities and dissolution properties were much better than that of MFA and TFA. Among them, the apparent solubility of the MFA–PPZ salt (1 : 1) improved about 130 times more than that of MFA in a mixture of water and ethanol. Meanwhile, these salts were non-hygroscopic based on dynamic vapor sorption analysis. Moreover, the obtained crystals were fully analyzed by single-crystal X-ray diffraction (SXRD), Hirshfeld surface analysis and a solvent mediated phase transformation study, which provided a better understanding of the crystal structure. The MFA–PPZ salt (2 : 1) and TFA–PPZ salt (2 : 1) possessed a similar crystal structure and their solubilities were also similar. In addition, the incorporation of PPZ in the crystal lattice destroyed the dimer form in the original MFA\TFA crystal and resulted in the formation of salts through a new ionic hydrogen bond. After contact with the solvents, PPZ was more likely to interact with the solvent molecules, which may have led to the acceleration of dissolution. … (more)
- Is Part Of:
- CrystEngComm. Volume 21:Issue 35(2019)
- Journal:
- CrystEngComm
- Issue:
- Volume 21:Issue 35(2019)
- Issue Display:
- Volume 21, Issue 35 (2019)
- Year:
- 2019
- Volume:
- 21
- Issue:
- 35
- Issue Sort Value:
- 2019-0021-0035-0000
- Page Start:
- 5284
- Page End:
- 5291
- Publication Date:
- 2019-08-09
- Subjects:
- Crystals -- Periodicals
Crystal growth -- Periodicals
Crystallography -- Periodicals
Cristaux -- Périodiques
Cristaux -- Croissance -- Périodiques
Cristallographie -- Périodiques
548 - Journal URLs:
- http://pubs.rsc.org/en/journals/journalissues/ce#!issueid=ce016040&type=current ↗
http://www.rsc.org/ ↗ - DOI:
- 10.1039/c9ce00781d ↗
- Languages:
- English
- ISSNs:
- 1466-8033
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3490.168000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11648.xml